The Latest in Rheumatology

Family Practice News

Duloxetine added to usual care doesn’t improve hip, knee OA pain

January 6, 2022

Family Practice News

Tofacitinib approved for new ankylosing spondylitis indication

December 16, 2021

Rheumatology

Family Practice News

Upadacitinib (Rinvoq) gains psoriatic arthritis as second FDA-approved indication

December 15, 2021

Rheumatology

Family Practice News

Validity of commercial serologic tests for dermatomyositis still questionable

November 24, 2021

Family Practice News

Platelet-rich plasma injections show no benefit in knee OA in placebo-controlled trial

November 23, 2021

Rheumatology

Family Practice News

Long-term glucocorticoids in RA linked to increased cardiovascular risk

November 17, 2021

Family Practice News

Tofacitinib postmarketing trial data shed light on JAK inhibitor risks

November 16, 2021

Family Practice News

Allopurinol proves noninferior to febuxostat for gout relief

November 12, 2021

Rheumatology

Family Practice News

mRNA COVID vaccine response found mostly robust in RA, SLE patients

November 11, 2021

Family Practice News

Drug combo at outset of polyarticular JIA benefits patients most

November 10, 2021

Family Practice News

Statins’ effects on CVD outweigh risk for diabetes in RA

November 9, 2021

Family Practice News

Lupus patients in remission see more flares with HCQ reduction, discontinuation

November 9, 2021

Rheumatology

Family Practice News

Risankizumab outperforms placebo at 6 months for psoriatic arthritis

November 8, 2021

Rheumatology

Family Practice News

Vitamin D and omega-3 supplements reduce autoimmune disease risk

November 7, 2021

Family Practice News

PT may lower risk of long-term opioid use after knee replacement

November 1, 2021